FREE SHIPPING ON ORDERS OVER $150

glutathione deficiency cancer Depletion and Stalwart Anticancer Activity of Metallotherapeutics Inducing Programmed Cell Death: Opening a New Window for Therapy Glutathione-mediated nanomedicines for cancer diagnosis

$27.68

Quantity
- +
Description

C.NoctorG.FoyerC

glutathione deficiency cancer Depletion and Stalwart Anticancer Activity of Metallotherapeutics Inducing Programmed Cell Death: Opening a New Window for Therapy Glutathione-mediated nanomedicines for cancer diagnosis

Cell Stem Cell 12 , 252264 (2013)

glutathione deficiency cancer Depletion and Stalwart Anticancer Activity of Metallotherapeutics Inducing Programmed Cell Death: Opening a New Window for Therapy Glutathione-mediated nanomedicines for cancer diagnosis

Phase II Detoxification Support : Conjugates with toxins and metabolic waste products through glutathione S-transferase pathways, facilitating their elimination from the body while supporting liver and kidney function

glutathione deficiency cancer Depletion and Stalwart Anticancer Activity of Metallotherapeutics Inducing Programmed Cell Death: Opening a New Window for Therapy Glutathione-mediated nanomedicines for cancer diagnosis

These compounds disrupt endocrine function through direct receptor binding and metabolic pathway interference

glutathione deficiency cancer Depletion and Stalwart Anticancer Activity of Metallotherapeutics Inducing Programmed Cell Death: Opening a New Window for Therapy Glutathione-mediated nanomedicines for cancer diagnosis

CARLIER, M.-B., LAURENT, G., CLAES, P.J., VANDERHAEGHE, H.J., & TULKENS, P.M

glutathione deficiency cancer Depletion and Stalwart Anticancer Activity of Metallotherapeutics Inducing Programmed Cell Death: Opening a New Window for Therapy Glutathione-mediated nanomedicines for cancer diagnosis

You may also like

AOD-9604

US$ 25.20

4.8 (29 reviews)

recommand products